Please use this identifier to cite or link to this item:
https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12945
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shen, H. | - |
dc.contributor.author | Huasen, B. B. | - |
dc.contributor.author | Killingsworth, M. C. | - |
dc.contributor.author | Bhaskar, S. M. M. | - |
dc.date.accessioned | 2024-09-02T05:56:46Z | - |
dc.date.available | 2024-09-02T05:56:46Z | - |
dc.date.issued | 2024 | - |
dc.identifier.issn | 20358385 (ISSN) | - |
dc.identifier.uri | https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12945 | - |
dc.description.abstract | Objective: This study aims to develop and validate the Futile Recanalization Prediction Score (FRPS), a novel tool designed to predict the severity risk of FR and aid in pre- and post-EVT risk assessments. Methods: The FRPS was developed using a rigorous process involving the selection of predictor variables based on clinical relevance and potential impact. Initial equations were derived from previous meta-analyses and refined using various statistical techniques. We employed machine learning algorithms, specifically random forest regression, to capture nonlinear relationships and enhance model performance. Cross-validation with five folds was used to assess generalizability and model fit. Results: The final FRPS model included variables such as age, sex, atrial fibrillation (AF), hypertension (HTN), diabetes mellitus (DM), hyperlipidemia, cognitive impairment, pre-stroke modified Rankin Scale (mRS), systolic blood pressure (SBP), onset-to-puncture time, sICH, and NIHSS score. The random forest model achieved a mean R-squared value of approximately 0.992. Severity ranges for FRPS scores were defined as mild (FRPS < 66), moderate (FRPS 66?80), and severe (FRPS > 80). Conclusions: The FRPS provides valuable insights for treatment planning and patient management by predicting the severity risk of FR. This tool may improve the identification of candidates most likely to benefit from EVT and enhance prognostic accuracy post-EVT. Further clinical validation in diverse settings is warranted to assess its effectiveness and reliability. � 2024 by the authors. | - |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
dc.subject | acute stroke clinical score endovascular thrombectomy futile recanalization prognosis risk prediction acetylsalicylic acid alteplase angiotensin receptor antagonist clopidogrel contrast medium dipeptidyl carboxypeptidase inhibitor tissue plasminogen activator adult aged algorithm Article atherosclerosis atrial fibrillation blood clot lysis blood pressure brain hemorrhage brain perfusion cardiovascular risk cerebrovascular accident CHA2DS2-VASc score clinical significance cognitive defect cohort analysis computer assisted tomography cross validation diabetes mellitus digital subtraction angiography female Glasgow coma scale human hyperlipidemia hypertension internal carotid artery learning algorithm machine learning major clinical study male mechanical thrombectomy middle aged molecular dynamics National Institutes of Health Stroke Scale patient care percutaneous thrombectomy perioperative period personalized medicine prediction predictor variable prevalence quality of life quantitative structure activity relation random forest Rankin scale recanalization reliability risk assessment scoring system subarachnoid hemorrhage systolic blood pressure treatment planning | - |
dc.title | Introducing the Futile Recanalization Prediction Score (FRPS): A Novel Approach to Predict and Mitigate Ineffective Recanalization after Endovascular Treatment of Acute Ischemic Stroke | - |
dc.type | Journal Article | - |
dc.contributor.swslhdauthor | Bhaskar, Sonu M. | - |
dc.description.affiliates | Global Health Neurology Lab, Sydney, 2150, NSW, Australia South West Sydney Clinical Campuses, UNSW Medicine and Health, University of New South Wales (UNSW), Sydney, 2170, NSW, Australia Department of Interventional Neuroradiology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, PR2 9HT, United Kingdom Edinburgh Medical School, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, EH16 4UX, United Kingdom Ingham Institute for Applied Medical Research, Cell-Based Disease Intervention Group, Clinical Sciences Stream, Liverpool, 2170, NSW, Australia NSW Brain Clot Bank, NSW Health Pathology, Sydney, 2170, NSW, Australia Department of Anatomical Pathology, NSW Health Pathology, Correlative Microscopy Facility, Ingham Institute for Applied Medical Research, Western Sydney University, Liverpool, 2170, NSW, Australia Department of Neurology & Neurophysiology, Liverpool Hospital, South West Sydney Local Health District, Liverpool, 2170, NSW, Australia | - |
dc.identifier.doi | 10.3390/neurolint16030045 | - |
dc.identifier.department | Liverpool Hospital, Department of Neurology and Neurophysiology | - |
dc.type.studyortrial | Article | - |
dc.identifier.journaltitle | Neurology International | - |
Appears in Collections: | Liverpool Hospital South Western Sydney Local Health District |
Files in This Item:
There are no files associated with this item.
Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.